Retraction

Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis

Paper Information

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.12997/jla.2022.11.1.87
Additional Notes:

see also: https://e-jla.org/search.php?where=aview&id=728233&code=9992JLA&vmode=FULL

Citations (5)

5
Total Citations
3
Post-Retraction
(60.0%)
1
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
548 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents
Vishal Mathur, Ozair Alam, Nadeem Siddiqui et al. (10 authors)
Molecules Open Access
Published: Aug 2023
34 citations
548 days after retraction
Pharmacophore Modeling and 3D QSAR Analysis of Pyrazole3-Carbohydrazone Derivatives as Dipeptidyl Peptidase IV Inhibitors for Type II Anti-Diabetic Therapy
Krishna Sarma Pathy
Unknown Journal Open Access
Published: Jan 2023
1 citation
334 days after retraction
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Vallo Volke, Urmeli Katus, Annika Johannson et al. (7 authors)
BMC Endocrine Disorders Open Access
Published: Oct 2022
17 citations
260 days after retraction
Quick Stats
Total Citations: 7
Years Since Retraction: 3.8 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Effects of an olmesartan/amlodipine fixed dose on blood pre…
Journal of Clinical Pharmacy and Therapeutics • 8 citations